Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What specific requirements does Hong Kong’s Good Distribution Practice (GDP) set for temperature and humidity monitoring in storage facilities, and how can we meet them?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q303 · Category G: Quality management and compliance systems (Q301–Q350)
Good Distribution Practice (GDP) requirements for temperature and humidity control are very strict because improper storage conditions can directly affect the stability and efficacy of medicines. First, medicines must be stored according to the label instructions (such as “Store below 25°C” or “Refrigerate at 2–8°C”). The warehouse must be equipped with a sufficient number of calibrated temperature and humidity monitoring devices to record data continuously. Based on the results of a temperature mapping study, the probes should be strategically positioned at points in the warehouse representative of extreme temperatures (the highest and lowest). Data records should be reviewed regularly (for example, daily). Any deviation from the pre-set range must be documented, and corrective and preventive action (CAPA) taken immediately. Backup power and alarm systems should also be provided to deal with unexpected power outages or equipment failures.

📘 Regulatory basis

The Drug Office, Department of Health’s Good Distribution Practice for Pharmaceutical Products and its technical guidelines set out in detail the requirements for temperature and humidity control, monitoring, recording and calibration in storage areas. These requirements are intended to ensure that medicines remain under the conditions specified on their labels throughout storage.

📗 Drew Tang's recommendations

We strongly recommend that clients invest in an automated electronic temperature and humidity monitoring system that complies with 21 CFR Part 11. Such systems provide real-time data, remote alerts and tamper-proof electronic records, greatly reducing the burden and risks of manual record-keeping. Temperature mapping studies should take into account different scenarios, such as a fully loaded and empty warehouse, and summer and winter conditions, to ensure the study is comprehensive. Calibration services must be performed by an accredited third-party organisation.

📕 Risk notice

Incomplete temperature and humidity records, uncalibrated monitoring equipment, or failure to take any action in response to temperature deviations are serious GDP breaches. If discovered, the regulator may consider the quality of your stock of medicines unreliable, may require you to destroy the affected batches, and may take action against your licence. This is an area that must never be taken lightly.

Back to Category G: Quality Management and Compliance Systems (Q301-Q350) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗